GSM2237202[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 3

Select item 2000844791.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease

(Submitter supplied) Approximately 10% to 20% of patients optimally treated for early Lyme disease develop persistent symptoms of unknown pathophysiology termed posttreatment Lyme disease syndrome (PTLDS). The objective of this study was to investigate associations between PTLDS and immune mediator levels during acute illness and at several time points following treatment. Seventy-six participants with physician-documented erythema migrans and 26 healthy controls with no history of Lyme disease were enrolled. more...

Organism:: synthetic construct; Homo sapiens

Type:: Protein profiling by protein array

Platform:: GPL18408
589 Samples

Download data: TXT

Series

Accession:: GSE84479

ID:: 200084479

Analyze with GEO2R

Select item 1000184082.

Stanford – Robinson Lab - Cytokine and Acute Phase Assays - 65 - v1.0

(Submitter supplied) Bead-based multiplex immunoassay Capture and secondary antibodies for sandwich immunoassay were commercially obtained and proprietary Protocol: The manufacturers’ recommended protocols and fully detailed instructions are available at http://www.bio-rad.com and http://www.millipore.com.